Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Crespo

Showing results (151-160 of 365) with videos related to

Pageof 37
Sort By:
International Journal of Molecular Sciences|April 17, 2019
LOXL2-A New Target in Antifibrogenic Therapy?Angela Puente, Jose Ignacio Fortea, Joaquin Cabezas, et al.
Nature Reviews. Gastroenterology & Hepatology|June 23, 2022
Ten steps to eliminating hepatitis C in hospitalsJosé Luis Calleja, Antonio Aguilera, Maria Buti, et al.
The American Journal of Medicine|September 20, 2020
An Elusive Diagnosis in Noncirrhotic Chronic Portal Vein ThrombosisJosé Ignacio Fortea, Angela Puente, Antonio Cuadrado, et al.
Journal of Clinical Medicine|May 13, 2026
MASLD Management in Spain: A Nationwide Survey of Gastroenterologists Highlighting Gaps in Risk Assessment and Primary Care CoordinationCarolina Jiménez-González, Paula Argos Vélez, Lorena Cayón, et al.
Transplantation Proceedings|January 4, 2025
SARS-CoV-2 Infection and Liver Transplant: How Are We Now?Carlos Gutiérrez García, Antonio Cuadrado, José Ignacio Fortea, et al.
Revista Espanola De Enfermedades Digestivas|December 20, 2016
Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapyÁngela Puente, Joaquín Cabezas, María Jesús López Arias, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB projectBlanca Sampedro, Cándido Hernández-López, José Ramón Ferrandiz, et al.
Clinical Reviews in Allergy & Immunology|January 25, 2013
Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel diseaseMaria Teresa Arias-Loste, Geovana Bonilla, Irene Moraleja, et al.
Headache|June 26, 2024
Differences in circulating alpha-calcitonin gene-related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross-sectional studyMarta Pascual-Mato, Gabriel Gárate, Vicente González-Quintanilla, et al.
Journal of Clinical Medicine|November 11, 2022
Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive ReviewAitor Odriozola, Ángela Puente, Antonio Cuadrado, et al.
Pageof 37

Showing results (151-160 of 365) with videos related to

Sort By:
Pageof 37
International Journal of Molecular Sciences|April 17, 2019
LOXL2-A New Target in Antifibrogenic Therapy?Angela Puente, Jose Ignacio Fortea, Joaquin Cabezas, et al.
Nature Reviews. Gastroenterology & Hepatology|June 23, 2022
Ten steps to eliminating hepatitis C in hospitalsJosé Luis Calleja, Antonio Aguilera, Maria Buti, et al.
The American Journal of Medicine|September 20, 2020
An Elusive Diagnosis in Noncirrhotic Chronic Portal Vein ThrombosisJosé Ignacio Fortea, Angela Puente, Antonio Cuadrado, et al.
Journal of Clinical Medicine|May 13, 2026
MASLD Management in Spain: A Nationwide Survey of Gastroenterologists Highlighting Gaps in Risk Assessment and Primary Care CoordinationCarolina Jiménez-González, Paula Argos Vélez, Lorena Cayón, et al.
Transplantation Proceedings|January 4, 2025
SARS-CoV-2 Infection and Liver Transplant: How Are We Now?Carlos Gutiérrez García, Antonio Cuadrado, José Ignacio Fortea, et al.
Revista Espanola De Enfermedades Digestivas|December 20, 2016
Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapyÁngela Puente, Joaquín Cabezas, María Jesús López Arias, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB projectBlanca Sampedro, Cándido Hernández-López, José Ramón Ferrandiz, et al.
Clinical Reviews in Allergy & Immunology|January 25, 2013
Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel diseaseMaria Teresa Arias-Loste, Geovana Bonilla, Irene Moraleja, et al.
Headache|June 26, 2024
Differences in circulating alpha-calcitonin gene-related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross-sectional studyMarta Pascual-Mato, Gabriel Gárate, Vicente González-Quintanilla, et al.
Journal of Clinical Medicine|November 11, 2022
Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive ReviewAitor Odriozola, Ángela Puente, Antonio Cuadrado, et al.
Pageof 37